Greenstone LLC has expanded its lineup of generic pharmaceuticals with the release of piroxicam capsules, an anti-inflammatory drug.


Greenstone, piroxicam capsules, authorized generic, Feldene, Pfizer, anti-inflammatory drug, nonsteroidal anti-inflammatory drug, NSAID, arthritis
































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Greenstone launches Feldene authorized generic

March 31st, 2014

PEAPACK, N.J. – Greenstone LLC has expanded its lineup of generic pharmaceuticals with the release of piroxicam capsules, an anti-inflammatory drug.

The company said its piroxicam product, which comes in dosages of 10 mg and 20 mg, both in 100-count sizes, is an authorized generic of Pfizer Inc.'s Feldene capsules.

Greenstone is a subsidiary of Pfizer.

A nonsteroidal anti-inflammatory drug (NSAID), piroxicam is indicated for relief of the signs and symptoms of osteoarthritis and rheumatoid arthritis.

Advertisement